HRA - Industry Notice - Rule Amendments

22 August 2019
Logo

The Members of Harness Racing Australia recently considered and approved a number of amendments to the Australian Harness Racing Rules (AHRR’s).  These amendments specifically deal with:
 

  • Eligibility For Registration (Genetic Engineering)
    • Amendment to AHRR 93(2)
       
  • Prohibited Substances (Bisphosphonates)
    • Additional wording AHRR 188A(1)(b)
    • Additional wording AHRR 190A(2)
    • Re-numbering within AHRR 190A(2)
    • Insert new AHRR 190AB – Bisphosphonates
       
  • General Offences (Blood Doping)
    • Inserted new AHRR 254(A) in Part 14 – General Offences under the heading Blood Doping

The actual amendments are set out below, with the date of effect to be determined by each State Controlling Body.
 

  1. AHRR 93 – ELIGIBILITY FOR REGISTRATION

The following amendment to Sub-rule (2) of Rule 93 was APPROVED:-

Save and except for embryo transfer or some other procedure approved by the Controlling Body a horse shall not be eligible for naming and/or registration and entry in the Australian Stud Book if it is the produce of genetic engineering procedures including but not limited to cloning, embryo freezing or oocyte collection.

 

  1. PROHIBITED SUBSTANCES (BISPHOSPHONATES)

The addition of the following wording to be added to AHRR 188A was APPROVED:

AHRR 188A

Add to Sub-rule 1(b) after “antitussive agents” the word “bisphosphonates”.

The addition of the following wording and renumbering applied to AHRR 190A(2) was APPROVED:

AHRR 190A

Add to Sub-rule (2) sub-paragraph (s) to read “unregistered bisphosphonates”.
 

  • The existing sub-paragraph (s) will become sub-paragraph (t).

The addition of the following wording to be inserted after Rule 190AA as new Rule 190AB was APPROVED:

Bisphosphonates

190AB

(1)  A horse must not at any time be administered an unregistered bisphosphonate.

(2)  Any person who:-

      (a)  Administers an unregistered bisphosphonate

      (b)  Attempts to administer an unregistered bisphosphonate

      (c)  Causes an unregistered bisphosphonate to be administered and/or

      (d) Is a party to the administration of or an attempt to administer any unregistered bisphosphonate

      to a horse is guilty of an offence.

(3)  Where the Stewards are satisfied that a horse has, or is likely to have been, administered an unregistered bisphosphonate contrary to this rule, the Stewards may prevent the horse from starting in any relevant race.

(4)  When a sample taken from a horse aged less than four years has detected in it a bisphosphonate the horse is not permitted to start in any race for a minimum period of twelve months from the date of the collection of the sample in which the bisphosphonate was detected.

(5)  When a sample taken from a horse aged four years or older has detected in it

      (a)  A registered bisphosphonate the horse is not permitted to start in any race for a minimum period of thirty days from the date of the collection of the sample in which the bisphosphonate was detected.

      (b)  An unregistered bisphosphonate the horse is not permitted to start in any race for a minimum period of twelve months from the date of the collection of the sample in which the bisphosphonate was detected.

(6)  When a sample taken from a horse has detected in it a bisphosphonate in breach of sub-rules (1), (4) or (5) the trainer and any other person who is in charge of such horse at the relevant time shall be guilty of an offence.
  

GENERAL OFFENCES (BLOOD DOPING)

The insertion of a new AHRR 254(A) in Part 14 – General Offences under the heading Blood Doping was APPROVED:

254A (1)   Subject to sub-rule (2) a person shall not either directly or indirectly withdraw from a horse, manipulate and reinfuse into a horse homologous, heterologous or autologous blood products or blood cells.

(2)  A registered veterinary surgeon may for lifesaving purposes or through use of veterinary regenerative therapies for the treatment of musculoskeletal injury withdraw from a horse, manipulate and reinfuse into a horse homologous, heterologous or autologous blood products or blood cells.

(3)  A horse that is treated in accordance with sub-rule (2) shall not be permitted to start in any race for a period of eight clear days from the date of the treatment.

(4)  A person who fails to comply with sub-rules (1), (2) or (3) is guilty of an offence.

 

Related News

19 April 2024
HRA - ANZAC Day Public Holiday - Closed Thursday 25th April
15 April 2024
Albion Park Harness Racing Club - Track Resurface
The Albion Park Harness Racing Club racing surface will undergo a full refurbishment next week, with current track material removed and a new surface laid. The project will commence on Sunday, April 21 and conclude on Thursday, April 25 in readiness for racing the following day. During the works, training...
12 April 2024
Baseline & Annual Cognitive Testing
On 1 February 2024, HRNSW implemented concussion protocols and procedures to provide additional protection to licensed Drivers, Trainers and Driving Stablehands. HRNSW reminds all Drivers that they are required to undertake an annual cognitive test as part of the licence renewal process. To date there...
11 April 2024
Racing WA - Handicapping & Programming Changes
At Racing WA, we’re making a focused effort to create more competitive racing, improve racing opportunities and consequentially increase wagering turnover on WA harness racing. Over the past two months or so, our new dynamic approach to race programming has seen increased field sizes and consistent...
10 April 2024
Screening Limits- Therapeutic Substances
Like most other international racing jurisdictions, HRA has in place formal screening limits for certain therapeutic substances. The therapeutic substances assigned screening limits are some commonly used equine medications representing a range of therapeutic classes, including nonsteroidal anti-inflammatory...
Click for more